Author

A. O. Adeshakin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

D. Yan· 1 shared F. O. Adeshakin· 1 shared G. Zhang· 1 shared L. Lin· 1 shared L. O. Afolabi· 1 shared L. Wang· 1 shared M. Zhang· 1 shared W. Liu· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

D. Yan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Regulation of lipid accumulation-induced ROS in myeloid-derived suppressor cells via targeting fatty-acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy

A. O. Adeshakin, W. Liu, F. O. Adeshakin, L. O. Afolabi, M. Zhang, G. Zhang, L. Wang, Z. Li, L. Lin, D. Yan, X. Wan

This study shows that inhibiting FATP2 in MDSCs reduces ROS and enhances anti-PD-L1 immunotherapy by improving T-cell function and reducing PD-L1 expression.

bioRxiv · Sep 28, 2020Immunology